Biolife Solutions Inc’s recently made public that its Director DuRoss Amy unloaded Company’s shares for reported $0.14 million on Mar 14 ’25. In the deal valued at $24.96 per share,5,632 shares were sold. As a result of this transaction, DuRoss Amy now holds 23,811 shares worth roughly $0.54 million.
Then, Aebersold Sarah sold 5,632 shares, generating $140,575 in total proceeds. Upon selling the shares at $24.96, the Chief Human Resources Officer now owns 45,860 shares.
Before that, Aebersold Sarah sold 2,695 shares. Biolife Solutions Inc shares valued at $68,561 were divested by the Chief Human Resources Officer at a price of $25.44 per share. As a result of the transaction, Aebersold Sarah now holds 43,165 shares, worth roughly $0.99 million.
H.C. Wainwright initiated its Biolife Solutions Inc [BLFS] rating to a Buy in a research note published on September 30, 2024; the price target was $29. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. Craig Hallum began covering BLFS with “Buy” recommendation on July 11, 2023. Oppenheimer revised its rating on April 25, 2022. It rated BLFS as “an Outperform” which previously was an “a Perform”.
Price Performance Review of BLFS
On Monday, Biolife Solutions Inc [NASDAQ:BLFS] saw its stock fall -12.02% to $22.84. Over the last five days, the stock has lost -13.52%. Biolife Solutions Inc shares have fallen nearly -12.02% since the year began. Nevertheless, the stocks have risen 23.73% over the past one year. While a 52-week high of $29.55 was reached on 01/30/25, a 52-week low of $14.84 was recorded on 03/31/25. SMA at 50 days reached $26.25, while 200 days put it at $24.67.
Levels Of Support And Resistance For BLFS Stock
The 24-hour chart illustrates a support level at 21.45, which if violated will result in even more drops to 20.07. On the upside, there is a resistance level at 24.93. A further resistance level may holdings at 27.03. The Relative Strength Index (RSI) on the 14-day chart is 36.48, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.42, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.09%. Stochastics %K at 48.89% indicates the stock is a holding.
How much short interest is there in Biolife Solutions Inc?
A steep rise in short interest was recorded in Biolife Solutions Inc stocks on 2025-03-14, growing by 92229.0 shares to a total of 3.47 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 3.37 million shares. There was a rise of 2.66%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 19, 2021 when B. Riley Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $61 price target.
